Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

BACKGROUND: Risk stratification of patients in the emergency department can be strengthened using prognostic biomarkers, but the impact on patient prognosis is unknown. The aim of the TRIAGE III trial was to investigate whether the introduction of the prognostic and nonspecific biomarker: soluble ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Martin, Rasmussen, Line Jee Hartmann, Andersen, Malene H., Stefansson, Jakob S., Falkentoft, Alexander C., Alstrup, Morten, Sandø, Andreas, Holle, Sarah L. K., Meyer, Jeppe, Törnkvist, Peter B. S., Høi-Hansen, Thomas, Kjøller, Erik, Jensen, Birgitte Nybo, Lind, Morten, Ravn, Lisbet, Kallemose, Thomas, Lange, Theis, Køber, Lars, Rasmussen, Lars Simon, Eugen-Olsen, Jesper, Iversen, Kasper Karmark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114851/
https://www.ncbi.nlm.nih.gov/pubmed/30153859
http://dx.doi.org/10.1186/s13049-018-0539-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114851/
https://www.ncbi.nlm.nih.gov/pubmed/30153859
http://dx.doi.org/10.1186/s13049-018-0539-5

Ejemplares similares